Ressenti des patients atteints de cancer pendant le premier confinement COVID-19 : quel impact sur le parcours de soins, l’état mental et l’accès aux soins oncologiques de support ?

Heitzmann, P.; Pelletier, Sylvie; Lecomte, Thierry; Maakaroun, Abadallah

doi:10.1016/j.bulcan.2022.11.008

Cited by 1 publication

(2 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…10 With the added burden of the COVID-19 pandemic, many people with cancer have had decreased access to mental health support at a time when there is even more uncertainty, fear, and anxiety than prior to the pandemic. 12,13 This has culminated in a mental health crisis, not only among people with cancer but more broadly in society since the onset of the pandemic in 2020. 14,15 A recently published ASCO guideline addressed the question "What are the recommended psychosocial, behavioral, and psychopharmacologic treatment approaches in the management of anxiety and/or depression in survivors of adult cancer?"…”

Section: Depressionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Integrative Oncology Care of Symptoms of Anxiety and Depression in Adults With Cancer: Society for Integrative Oncology–ASCO Guideline

Carlson,

Ismaila,

Addington

et al. 2023

JCO

View full text Add to dashboard Cite

PURPOSE To provide evidence-based recommendations to health care providers on integrative approaches to managing anxiety and depression symptoms in adults living with cancer. METHODS The Society for Integrative Oncology and ASCO convened an expert panel of integrative oncology, medical oncology, radiation oncology, surgical oncology, palliative oncology, social sciences, mind-body medicine, nursing, methodology, and patient advocacy representatives. The literature search included systematic reviews, meta-analyses, and randomized controlled trials published from 1990 through 2023. Outcomes of interest included anxiety or depression symptoms as measured by validated psychometric tools, and adverse events. Expert panel members used this evidence and informal consensus with the Guidelines into Decision Support methodology to develop evidence-based guideline recommendations. RESULTS The literature search identified 110 relevant studies (30 systematic reviews and 80 randomized controlled trials) to inform the evidence base for this guideline. RECOMMENDATIONS Recommendations were made for mindfulness-based interventions (MBIs), yoga, relaxation, music therapy, reflexology, and aromatherapy (using inhalation) for treating symptoms of anxiety during active treatment; and MBIs, yoga, acupuncture, tai chi and/or qigong, and reflexology for treating anxiety symptoms after cancer treatment. For depression symptoms, MBIs, yoga, music therapy, relaxation, and reflexology were recommended during treatment, and MBIs, yoga, and tai chi and/or qigong were recommended post-treatment. DISCUSSION Issues of patient-health care provider communication, health disparities, comorbid medical conditions, cost implications, guideline implementation, provider training and credentialing, and quality assurance of natural health products are discussed. While several approaches such as MBIs and yoga appear effective, limitations of the evidence base including assessment of risk of bias, nonstandardization of therapies, lack of diversity in study samples, and lack of active control conditions as well as future research directions are discussed. Additional information is available at www.asco.org/survivorship-guidelines .

show abstract